首页> 美国卫生研究院文献>other >GeneOptimizer Program-assisted cDNA Reengineering Enhances sRAGE Autologous Expression in Chinese Hamster Ovary Cells
【2h】

GeneOptimizer Program-assisted cDNA Reengineering Enhances sRAGE Autologous Expression in Chinese Hamster Ovary Cells

机译:GeneOptimizer程序辅助的cDNA工程改造增强了中国仓鼠卵巢细胞中sRAGE的自体表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Soluble receptor for advanced glycation end products (sRAGE) is a secreted mammalian protein that functions as a decoy to counter-react RAGE signaling-resultant pathological conditions, and has high therapeutic potentials. Our prior studies showed that recombinant human sRAGE expressed in Chinese hamster, C. griseus, ovary (CHO) cells is modified by specific N-glycosylation, and exhibits higher bioactivity than that expressed in other host systems including insect S. frugiperda cells. Here, we show that GeneOptimizer software program-assisted, reengineered sRAGE cDNA enhances the recombinant protein expression in CHO cells. The cDNA sequence encoding human sRAGE was optimized for RNA structure, stability, and codon usages in CHO cells. We found that such optimization augmented sRAGE expression over 2 folds of its wild-type counterpart. We also studied how individual parameter impacted sRAGE autologous expression in CHO cells, and whether sRAGE bioactivity was compromised. We found that the enhanced expression appeared not to affect sRAGE N-glycosylation and bioactivity. Optimization of sRAGE expression provides a basis for future large-scale production of this protein to meet medical needs.
机译:晚期糖基化终产物(sRAGE)的可溶性受体是一种分泌的哺乳动物蛋白,其功能是与RAGE信号转导的病理状态产生反作用的诱饵,具有很高的治疗潜力。我们的先前研究表明,在中国仓鼠,灰褐色,卵巢(CHO)细胞中表达的重组人sRAGE被特异性N-糖基化修饰,并且比在包括昆虫S. frugiperda细胞在内的其他宿主系统中表达的生物活性更高。在这里,我们显示了GeneOptimizer软件程序辅助,重新设计的sRAGE cDNA可增强CHO细胞中重组蛋白的表达。编码人sRAGE的cDNA序列针对CHO细胞中的RNA结构,稳定性和密码子使用进行了优化。我们发现这种优化使sRAGE表达增加了其野生型对应物的2倍。我们还研究了单个参数如何影响CHO细胞中sRAGE自体表达,以及sRAGE生物活性是否受到损害。我们发现增强的表达似乎不影响sRAGE N-糖基化和生物活性。 sRAGE表达的优化为将来大规模生产这种蛋白质以满足医学需求提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号